Form EFFECT NeuBase Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 2, 2024 |
| Accession Number: | 0001104659-24-075712 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WRENSILVA PRESENTS: THE ART OF THE ALBUM FEATURING THE PHOTOGRAPHY OF LINDA MCCARTNEY
- Houston Texans Linebacker Azeez Al-Shaair Partners With Human Development Fund on Welcome Home Kits for Houston Families
- JLL Income Property Trust Acquires Greater Boston Area Warehouse
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
